Ceragenix Pharmaceuticals

Ceragenix to Present at Rodman & Renshaw Third Annual Global
dBusinessNews.com - DENVER -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix"), a biopharmaceutical company focused on infectious disease and dermatology, today announced that Steven Porter, Chairman and CEO of Ceragenix, will present at the Rodman & Renshaw 3rd Annual

Latest News
dBusinessNews.com - Denver: Chipotle Mexican Grill, Inc. to Announce First Quarter 2006 Results on May 8, 2006 DENVER -- Chipotle Mexican Grill, Inc. (NYSE:CMG), the Denver-based burrito Denver: New Tax Update from IXG - IRS Gives 'Blessing' to Related Parties

business Colorado business, 5/2
Denver Post - Tattered Cover Book Store announced Monday it is seeking original designs for a T-shirt intended to celebrate its move to the Lowenstein Theatre redevelopment project on East Colfax Avenue. The bookstore has been a fixture in Cherry Creek North for

Ceragenix Compound Demonstrates Activity Against MRSA Biofilm
Medical News Today - Ceragenix Pharmaceuticals, Inc. today announced that in vitro testing performed by MBEC BioProducts (www.mbec.ca) has shown that its Ceragenin compound, CSA-13, was over 100 fold more effective in eradicating a methicillin resistant Staphylococcus